Biotech Business Week articles from August 2004

Biotech Business Week archives from August 2004

First patient enrolled in FLAME clinical trial.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced that enrollment has begun in its clinical trial known as FLAME. This prospective, multicenter, randomized study will involve approximately 500 patients...

Multicenter trial of Aquapheresis therapy initiated.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- CHF Solutions, Inc., announced that enrollment has begun in a large clinical trial to evaluate its unique Aquapheresis therapy compared with traditional diuretic therapy. Administered via CHF...

FDA approves NeutroSpec imaging agent to help detect appendicitis.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Mallinckrodt, a business unit of Tyco Healthcare, and its strategic collaboration partner, Palatin Technologies, Inc., Cranbury, New Jersey, received approval from the U.S. Food and Drug Administration...

Successful phase Ia trial results reported on anti-obesity compound.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Arena Pharmaceuticals, Inc., (ARNA) announced results from a phase Ia, single-dose clinical trial of the company's novel anti-obesity compound, APD356. APD356 is an orally administered small...

Confidentiality of genetic databases questioned by researchers.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- In their exuberance over cracking the genetic code, scientists have paid too little attention to privacy issues, according to researchers at the Stanford University School of Medicine. Their...

Survey uncovers life sciences industry trends.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Foley & Lardner, LLP, released the results of its first annual "Life Sciences Survey" which examined key issues and opportunities facing executives within the life sciences industry. Despite an...

Company approves prototype design of liposuction handle.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Cell Bio-Systems, Inc., (CBSI), a biotechnology company positioned to manufacture and distribute patented, disposable technologies for cosmetic surgery and other living tissue procedures, has approved...

FDA approves phase III study design for PreHistin.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- BioGentech Corp. (BGTH) has received a letter from the U.S. Food and Drug Administration (FDA) in which the FDA confirmed that two phase III study designs submitted by BioGentech for review effectively...

Tentative approval granted for Allegra-D extended-release tablets.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Barr Pharmaceuticals, Inc., (BRL) announced that Barr Laboratories, Inc., has received tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of Aventis...

Enrollment closes in phase III trial with Phenserine.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Axonyx, Inc., (AXYX) announced that it has completed enrollment in the first of its two on-going phase III clinical studies evaluating Phenserine in patients with mild to moderate Alzheimer disease. ...

Group supports Medicare reimbursement for brain scans.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- In the hope that it will drive early intervention for the increasing number of Americans with Alzheimer disease, the Alzheimer's Foundation of America (AFA) announced its support of the federal...

Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Researchers have found that a large protein, alsin, is a Rab5 and Rac1 guanine nucleotide exchange factor, and may play a role in a juvenile form of amyotrophic lateral sclerosis. "ALS2 is the gene...

Agreement with FDA reached on clinical development program for diltiazem.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- DOV Pharmaceutical, Inc., (DOVP) has reached agreement with the FDA's (U.S. Food and Drug Administration) Cardio-Renal Division on the scope and design of the clinical trials required for submission of...

Pharmacists highlight antibiotic misunderstanding and overuse in public survey.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The Royal Pharmaceutical Society of Great Britain (RPSGB) highlighted the need for better understanding of how antibiotics work as part of the campaign to prevent antibiotic resistance. But a...

New methods ease the separation of antisense oligonucleotide in plasma.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- New methods ease the separation of antisense oligonucleotide in plasma. "A novel approach is presented for the direct injection, and subsequent separation, of antisense phosphorothioate...

European approval sought for Xolair as treatment for severe allergic asthma.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Novartis Pharma AG has submitted its application for the European approval of Xolair. Xolair (omalizumab) is a novel therapy, which targets a root cause of allergic disease and offers an entirely...

Hundreds of athletes with asthma compete in Athens.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- A diagnosis of asthma used to mean a seat on the bench for amateur and professional athletes. But with advances in asthma treatment and management, asthma - not the athlete - is sent to the...

Oxidized lipids, antibodies may be markers for atherogenesis.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The oxidation hypothesis of atherogenesis has been studied and researchers report new evidence that oxidized lipids and antibodies in those lipids may play a role as markers for atherogenesis. "The...

U.S. pharmacy group to distribute nutritional supplement.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Australian Cancer Technology Limited (ACU) announced that its U.S. subsidiary, ACT (USA), has signed a distribution deal with Rochester Drug Cooperative, which will see the revisys range of nutritional...

Ernst & Young names biotech president, CEO Eastwood entrepreneur of the year.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Jackie Eastwood, president and CEO, TissueLink Medical, Inc., was named the 2004 Ernst & Young New England Entrepreneur Of The Year in the Medical Devices category. This is the 18th year Ernst &...

Pharmaceutical innovation award program announced.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Microsoft Corp. (MSFT) announced the first Microsoft Pharmaceutical Innovation Award program, sponsored by Proscape Technologies Inc. Through this annual award, Microsoft will recognize the...

Imaging agent launched for preclinical computed tomography.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Alerion Biomedical, Inc., a company developing diagnostic and therapeutic products based on its molecular targeting technologies, has launched Fenestra, its first contrast enhancement product line for...

Atomic force microscopy useful for analysis of adsorbed antibodies.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Atomic force microscopy (AFM) is useful for analysis of immobilized antibodies. "Antibody adsorption to solid surfaces creates a number of constraints that may interfere with epitope recognition and...

Biosensors identify DNA binding at the single molecular level.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Biosensors identify DNA binding at the single molecular level. According to published research from Japan, "a novel method for detecting interaction between DNA and DNA-binding protein at the...

Korean regulatory body approves blood plasma volume expander.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- BioTime, Inc., (BTX) announced that its South Korean licensing partner CJ Corp. has received regulatory approval from the Korea Food and Drug Administration (KFDA) for Hextend, the company's...

Alliance formed to increase access to partial breast irradiation.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Varian Medical Systems, Inc. (VAR) and Proxima Therapeutics, Inc. have formed an alliance to increase access to high-dose-rate radiation (HDR) therapy equipment for hospitals interested in offering...

Cancer therapeutics development company files IND for metastatic breast cancer.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- NeoRx Corporation (Nasdaq:NERX) announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a phase II clinical study of STR (skeletal...

Biomaterials developer announces closing of common stock sale to Angiotech.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Orthovita, Inc., (NASDAQ NM:VITA) closed the sale of 5,681,818 shares of its common stock to Angiotech Pharmaceuticals, Inc. Gross proceeds for the sale total $25 million, reflecting approximately...

Biomedical company closes $3 million private placement.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Response Biomedical Corp. (TSX-V: RBM) announced that it has received gross proceeds of $3 million and closed the non-brokered private placement. The private placement, subscribed in full by Othmar...

Indoor positioning solutions company for healthcare announces Series A financing.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Radianse, Inc., announced the completion of a $9 million Series A financing round. The deal boosted the potential for active radio frequency identification (RFID) with real-time location to make an...

Information technology company completes $4 Million credit facility.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- ProVation Medical, Inc. announced that it closed a $4 million credit facility with Silicon Valley Bank (SVB). The agreement marks a new business relationship between the bank and the...

Integrated eye care services company expects earnings restatement.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- OptiCare Health Systems, Inc., (AMEX:OPT) announced that it is conducting a review of its previously reported financial statements. The review will be conducted for the quarter ended March 31, 2004,...

Medical technology company lists on London AIM Exchange, reports on options.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Norwood Abbey Ltd. (OTC:NABYF) (ASX:NAL) advises that the securities of its subsidiary Norwood Immunology Ltd (NIM) have commenced trading on London's Alternative Investment Market (AIM:NIM). The...

Membership marketing company announces share repurchase authorization.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Precis, Inc. (NASDAQ: PCIS) announced that its board of directors has approved the repurchase of up to 500,000 shares of PCIS common stock. The stock purchase will be executed in open market or...

Pain management company closes $3 million of institutional financing.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- PainCare Holdings, Inc., (AMEX:PRZ) announced that it has completed two separate institutional private placement offerings with aggregate proceeds of $3 million to existing investors in the company. ...

Personal care products marketer applies for NASDAQ national market listing.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Natural Health Trends Corp. (OTC BB: NHLC) announced that it filed an application during the second quarter of 2004 to list the company's common stock on the NASDAQ National Market System. Mark...

Pharma company announces exercise of over allotment option.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Pharmion Corporation (NASDAQ:PHRM) announced that the underwriters of its previously announced offering of common stock have exercised in full their over allotment option and agreed to purchase an...

Pharmaceutical company added to Russell 2000 Index.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Pharmos Corporation (NASDAQ:PARS) announced that the company has been added to the Russell 2000 Index, a subset of the Russell 3000 Index. The Russell 3000 comprises 3,000 of the largest U.S....

Pharmaceutical group announces that joint venture is operational.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Hubei Pharmaceutical Group (HBEI) announced that its new joint venture, a 60% controlling interest in Hubei Tongji Benda Ebei Pharmaceutical Co. Ltd. (HBBendaJV), located in Guangshui City, Hubei...

Point-of-care rapid diagnostic test provider expects second quarter loss.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Quidel Corporation (Nasdaq:QDEL) announced that second quarter 2004 total revenues are expected to be approximately $14.3 million, including approximately $13.7 million in product sales. The...

Projected per share earnings from Health Care Horizons acquisition clarified.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Molina Healthcare, Inc., (NYSE:MOH) has issued a clarification of its release made earlier regarding the anticipated per share earnings accretion resulting from its acquisition of Health Care Horizons....

Alprox-TD license, supply and distribution agreement signed with Schering.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- NexMed, Inc., (NASDAQ:NEXM) announced that it has entered into a license, supply and distribution agreement with Schering AG, Germany (NYSE: SHR; FSE: SCH). This agreement provides Schering with...

Approval received to market Lyrica in Europe.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Pfizer Inc said that it has received approval from the European Commission to market Lyrica (pregabalin) in all European Union member states for the treatment of peripheral neuropathic pain and as an...

Biopharmaceutical company announces contract with GlaxoSmithKline.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- ProMetic Life Sciences Inc. (TSX: PLI) announced that its wholly owned subsidiary ProMetic BioSciences Ltd. has signed a contract with GlaxoSmithKline (GSK) to provide GSK access to ProMetic's unique...

Biosafety lab expansion, patent issuance and biodefense reagents sale announced.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Commonwealth Biotechnologies, Inc., (NASDAQ: CBTE) announced completion of its new virology biosafety level 3 laboratory within its accredited BSL-3 suite. Construction and fit-out of the new lab...

Biotech firm establishes new international headquarters.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Biogen Idec (BIIB) officially opened its new international headquarters in Zug, Switzerland. With its global commercial and administrative operations headquartered in Switzerland, Biogen Idec will...

Certificate of Suitability granted for Cephradine.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) announced that it has been granted the Certificate of Suitability (CoS) by the European Directorate for the Quality of Medicines (EDQM) for its API...

Development and supply agreement forged with Kendall for bone biopsy needles.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Specialized Health Products International, Inc., (OTCBB: SHPI) and Kendall announced a worldwide development and OEM supply agreement related to the marketing and sale of safety bone marrow biopsy...

Drug discovery company spins off peptide technologies business unit.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Jerini AG has transferred its peptide technologies business unit to a wholly owned subsidiary to ensure further growth and increased market penetration. Under the direction of former business unit...

FDA approval granted for new biopharmaceutical production plant.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Boehringer Ingelheim has received official approval for its new biopharmaceutical active ingredients production plant following an inspection of the plant at the Biberach (Riss) site by the U.S. Food...

First payment made in Therapik multi-year agreement.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The Jenex Corporation (JEN) has received their first payment of $77,500 from the previously announced exclusive multi-year agreement with Daeyang E&C of Korea. Daeyang will manufacture and market...

Licensing agreement forged for antiphospholipid therapy technology.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Peregrine Pharmaceuticals (NASDAQ:PPHM) announced that it has completed a worldwide exclusive licensing agreement for intellectual property related to anti- phosphatidylserine (anti-PS) antibodies. ...

Life Sciences Partnership announces incubator graduate, Crystalplex Corporation.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The Pittsburgh Life Sciences Greenhouse (PLSG) announced that Crystalplex Corporation has expanded and will move to larger facilities, serving as the first "alumnus" of the PLSG Incubator. ...

Ligand announces $1 million milestone payment.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Ligand Pharmaceuticals Incorporated (LGND) announced that TAP Pharmaceutical Products Inc. has selected an additional selective androgen receptor modulator (SARM) as a second clinical candidate for...

London biotech company moves to The Stiller Centre for Biotechnology.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Plantigen Inc. has moved to The Stiller Centre for Biotechnology. The company is the first spin-off of the Lawson Health Research Institute to mature into its own space. According to Mary Gardner,...

New contracts announced for biodefense-related contract work.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Commonwealth Biotechnologies, Inc., (NASDAQ SmallCap Market: CBTE) announced additional new biodefense related contract work. The new contracts total nearly $1.2 million and are with government and...

New health/pharmaceutical government staff directory launched.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Congressional Quarterly's CQ Press Division has launched a new directory for anyone involved in the health and pharmaceutical industries. The directory lists Municipal, State, Congressional and...

Nine of top ten pharmaceutical companies attend user conference.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- IntelliChem, Inc., held its first global user meeting in New York City to discuss the most pressing issues facing pharmaceutical companies as they deploy intelligent electronic lab notebooks (i ELN)...

Pharmaceutical company announces E.U. regulatory approval for T-GO.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Sinclair Pharma plc (Sinclair) announced the receipt of E.U. regulatory approval as a medical device for a newly patented product, T-GO, a treatment for painful throat conditions such as pharyngitis....

Pharmaceutical company enters license agreement for SubQ aesthetic product.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Medicis (MRX) has entered into an exclusive license agreement with Q-Med AB to market, distribute, sell, and commercialize in the United States and Canada Q-Med's product currently known as SubQ, an...

Pharmaceutical company seeks new independent auditor.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- KV Pharmaceutical Company (KVa/KVb) has filed a Form 8-K with the U.S. Securities and Exchange Commission notifying the Commission of the resignation of its independent auditor, BDO Seidman, LLP. ...

Pharmaceutical firm works to become advanced drug discovery chemistry provider.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- AFID Therapeutics, Inc., announced the launch of the first phase of its campaign to establish itself as the provider of the most advanced drug discovery chemistry in the industry. An array of...

Early stage cancers could be predicted with accuracy by confocal laser endoscopy.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The significance of cancer diagnosis trial results from the new flexible endo-microscope, jointly developed by Optiscan and Pentax, has been recognized by the prestigious international medical journal,...

Biopharmaceutical company announces promotion agreement for Kadian.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- MGI Pharma, Inc., (MOGN) has entered into a 3-year agreement with Alpharma, Inc., to promote Alpharma's sustained release morphine sulfate product, Kadian. Under the terms of this promotion...

New prostate cancer guidelines validate PSA and free PSA screening tests.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- New guidelines from the independent National Comprehensive Cancer Network (NCCN) strongly support the prostate specific antigen (PSA) and percent-free PSA blood tests to aid in the detection and...

Catalytic antioxidant inhibits tumor regrowth following radiation therapy.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Incara Pharmaceuticals Corporation (ICRA) has announced further data that demonstrate that the administration of a compound, AEOL 10113, from the company's class of proprietary catalytic antioxidants...

DNABarrier cancer treatment licensed to Chinese biotechnology corporation.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Mologen announced licensing of its dSLIM-based DNABarrier II to the Chinese biotechnology corporation Starvax Inc. of Beijing, PR China. DNABarrier II is one of three applications currently under...

First batch of cGMP paclitaxel produced by manufacturer.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Bioxel Pharma, Inc., (BIP), a manufacturer of naturally derived taxanes and targeted oncology drugs, announced the release and sale of its first kilogram scale lots of cGMP paclitaxel from the new...

Nanomedicine global developments and growth opportunities explored.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The adoption of nanotechnology-based applications by large therapeutic and diagnostic companies is accelerating the development of nanomedicine. The prospect of site-specific therapeutic action and...

National Cancer Institute grant received to develop multiplex cell assay.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- PharmaSeq announced the receipt of a Phase I SBIR grant from the U.S. National Cancer Institute, a branch of U.S. National Institutes of Health (NIH). The main goal of the research is to develop a...

Patent issued for method to predict effectiveness of chemotherapy.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- U.S. Patent and Trademark Office granted patent gene methylation technology for the prediction of clinical response to certain types of chemotherapeutic treatment of cancer patients. The treatment...

Mechanism of benzene-induced leukemia elucidated.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The mechanism of benzene-induced leukemia has been elucidated. According to published research from the United States, "Acute myeloid leukemia and chronic lymphocytic leukemia are associated with...

Company reports rapid adoption of AutoPulse Resuscitation System.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Revivant Corp. announced it has ended the June quarter of 2004 with 25 new customers purchasing AutoPulse Resuscitation Systems during the quarter. The AutoPulse is a noninvasive CPR device that...

Saint-Gobain to install AEDs at work sites.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Saint-Gobain Corporation has purchased automated external defibrillators (AEDs) to treat employees who may suffer from sudden cardiac arrest while on the job, Medtronic has announced. The first...

AI-700 collaboration, license and supply agreement forged with Acusphere.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Nycomed announced that it has entered into a collaboration, license and supply agreement with Acusphere Inc. (NASDAQ: ACUS). The agreement grants Nycomed the rights to develop and market...

Prescriptions increase for cataplexy associated with narcolepsy.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Orphan Medical, Inc., (ORPH) announced that the total number of filled Xyrem (sodium oxybate) oral solution prescriptions in the 6-week period ended June 30, 2004, were 3425, up 16% over the prior...

OTC statin options discussed at inaugural meeting of Midwest Lipid Association.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The National Lipid Association (NLA) announced the inaugural meeting of the Midwest Lipid Association (MWLA). More than 100 lipid specialists primarily from around the Midwestern United States are...

Mechanisms of transition from acute to chronic muscle pain.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Certain mechanisms of transition occur from acute to chronic muscle pain. According to published research from Germany, "The present article presents an overview of neurophysiological and...

GMP approval granted by Belgium authorities for CellSpray manufacture.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Clinical Cell Culture, Ltd., (C3, CCE) announced that the Belgium Health Authorities have authorized Cambrex, C3's European contract manufacturer, to manufacture CellSpray and CellSpray XP on behalf of...

Endo Pharmaceuticals announces agreement for Oxymorphone ER trial design.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Penwest Pharmaceuticals Co. (NASDAQ:PPCO) announced that its development partner Endo Pharmaceuticals Holdings Inc. has reached agreement with the U.S. Food and Drug Administration (FDA) on the design...

Process uses riboflavin and light to reduce pathogens in donated blood.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Targeting the improved safety of transfusion medicine, the Mirasol PRT process uses riboflavin (also known as vitamin B2) and light to reduce the level of pathogens found in donated blood components,...

Agreement signed for Kadian in cancer pain.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Alpharma, Inc., (ALO) announced that it has entered into a 3-year agreement with MGI Pharma, Inc., an oncology focused biopharmaceutical company, for the promotion of Alpharma's Kadian product, a...

Agreement signed for glaucoma, ocular hypertension treatment.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- R-Tech Ueno, Ltd., (headquartered Sanda, Hyogo, Japan) and Santen Pharmaceutical Co., Ltd., (headquartered Osaka, Japan) announced that Santen will acquire the exclusive marketing rights in Japan for...

Agreement signed with Artemis Pharmaceuticals for transgenic mice.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Biovitrum AB and Artemis Pharmaceuticals GmbH, Cologne, have signed a research services agreement concerning the generation of RNAi-modified transgenic mice for the in vivo functional analysis of...